Author: Publisher:
ISBN:
Category :
Languages : en
Pages : 637
Book Description
Prostaglandins in Clinical Research, Cardiovascular System
Author: Prostaglandins in Clinical Research, Cardiovascular System
Author: Karsten SchörrPublisher: Alan R. Liss
ISBN:
Category : Medical
Languages : en
Pages : 680
Book Description
Prostaglandins in Clinical Research
Author: Progress in Clinical and Biological Research
Author: George J. BrewerPublisher:
ISBN: 9780845151518
Category : Biology
Languages : en
Pages : 637
Book Description
Prostaglandins and the Cardiovascular System
Author: John A. OatesPublisher:
ISBN: 9780890045800
Category : Appareil cardiovasculaire
Languages : en
Pages : 388
Book Description
Prostaglandins and Other Eicosanoids in the Cardiovascular System
Author: Karsten SchrörPublisher: S. Karger AG (Switzerland)
ISBN:
Category : Medical
Languages : en
Pages : 596
Book Description
Prostaglandins in the Cardiovascular System
Author: Helmut SinzingerPublisher: Birkhauser
ISBN:
Category : Cardiovascular system
Languages : en
Pages : 402
Book Description
Prostacyclin and Its Stable Analogue, Iloprost
Author: Ryszard GryglewskiPublisher: Springer
ISBN:
Category : Medical
Languages : en
Pages : 344
Book Description
Ten years after the discovery of prostacyclin, our knowledge of its biochemical mode of action, pharmacological properties, pathophysiological significance and therapeutic applications is ever expanding. Prostacyclin is both complex and unique as demonstrated by its unusual feature of being chemically and meta bolically unstable when compared to other prostanoids and known amine or peptide mediators. Although physiologically essential, the chemical instability of prostacyclin poses a serious drawback in laboratory and clinical studies. It is one of the genuine objectives of pharmaceutical research to supply synthetic compounds which overcome the inherent drawbacks - considering investigational and therapeutic use - of endogenous compounds. Whereas metabolic instability in certain cases could be of advantage, chemical instability definitely is not. With Iloprost, a molecule has been designed which - according to all data so far available - pertains high receptor affinity, metabolic instability (clinically this equates with a fine control of Iloprost's effects) while chemical stability has been achieved. By virtue of these characteristics Iloprost can be considered as one step towards specific interaction within the arachidonic acid cascade, namely the prostacyclin receptor. The aim of the symposium was to provide a critical experimental appraisal concerning the biochemical mode of action and pharmacological properties of prostacyclin and Iloprost.
Advances in Prostaglandin and Thromboxane Research: Prostoglandins and the cardiovascular system
Author: Bengt SamuelssonPublisher:
ISBN:
Category : Cardiovascular system
Languages : en
Pages : 402
Book Description
Prostaglandins, Platelets, Lipids
Author: Hadley L. ConnPublisher: Elsevier
ISBN: 1483165132
Category : Medical
Languages : en
Pages : 165
Book Description
Prostaglandins, Platelets, Lipids: New Developments in Atherosclerosis focuses on developments pertaining to atherosclerosis and suggested novel approaches for its prevention, treatment, and complications. The selection first underscores the biological importance and therapeutic potential of prostacyclin and rationale for the suppression of platelet aggregation and thrombosis by dietary manipulation of fatty acids. Discussions focus on eicosapentaenoic acid as a potential antithrombotic substance, vascular effects of prostacyclin, antithrombotic and hemostatic effects of prostacyclin, fatty acids, prostacyclin, and thrombosis, and therapeutic uses of prostacyclin. The text then examines prostaglandins and hypertension, role of platelets in stroke and transient ischemic attack, and antiplatelet agents in the prevention of acute coronary events. Topics include thrombosis and clinical complications of atherosclerosis, mechanisms in thrombosis, vascular prostaglandins and antihypertensive mechanisms, and renal prostaglandins and antihypertensive mechanisms. The book ponders on a specific inhibitor of thrombin and cardiovascular actions of prostacyclin in man, including prostacyclin and angina pectoris, prostacyclin therapy for peripheral arterial disease, and hemodynamic changes induced by prostacyclin. The selection is a dependable source of data for researchers interested in atherosclerosis.